10 SU2C Catalyst® collaborative clinical trial projects combine treatments from 9 pharma
(Entertainment Industry Foundation) 10 SU2C Catalyst® clinical trial projects awarded, collaborating across academic /industry borders, and correlated translational research will deepen understanding of why treatments are effective. The research community proposed how best to combine treatments in any setting, including some triple combinations. SU2C Catalyst aims at learning how to prime people to respond, not just asking if a combination works, but digging into the why. SU2C Catalyst's construct reduces SU2C's time to get trials started >75 percent.